Latest Close
$3.69
News
ADAG
Adagene Inc. News
This news view pulls recent coverage and headlines tied to ADAG.
1y Change
$2.09 (+130.63%)
Market Cap
$243,807,872.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Adagene (ADAG) Partners With Incyte (INCY) to Evaluate Combination Therapy for Colorectal Cancer
Insider Monkey • Apr 20, 2026
Read articleAdagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
GlobeNewswire • Apr 17, 2026
Read articleAdagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
GlobeNewswire • Apr 14, 2026
Read articleIncyte (INCY) Is Up 6.2% After Positive Povorcitinib Data And New Oncology Collaboration - Has The Bull Case Changed?
Simply Wall St. • Apr 5, 2026
Read articleSector Update: Health Care Stocks Decline Premarket Thursday
MT Newswires • Apr 2, 2026
Read articleAdagene, Incyte to Evaluate Muzastotug, INCA33890 in Microsatellite Stable Colorectal Cancer
MT Newswires • Apr 2, 2026
Read article